Bausch Health Companies Inc. buy tamam
Start price
14.12.18
/
50%
€21.56
Target price
17.12.18
€29.80
Performance (%)
-12.11%
End price
17.12.18
€18.95
Summary
This prediction ended on 17.12.18 with a price of €18.95. The prediction for Bausch Health Companies Inc. disappointed with a performance of -12.11%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bausch Health Companies Inc. | 0.978% | 0.978% | -32.269% | -34.649% |
| iShares Core DAX® | -1.742% | -10.677% | -0.889% | 48.094% |
| iShares Nasdaq 100 | -2.583% | -3.319% | 11.124% | 74.134% |
| iShares Nikkei 225® | -1.165% | -9.362% | 23.687% | 48.880% |
| iShares S&P 500 | -1.422% | -3.762% | 7.187% | 57.428% |
Comments by tamam for this prediction
In the thread Bausch Health Companies Inc. diskutieren
Bausch Health Companies Acquires 2 Possible Blockbuster Drugs for $200 Million from SGYP
tamam stimmt am 14.12.2018 der Buy-Einschätzung von Subdi mit dem Kursziel 29,8$ zu.
Überschrift: Name change to Bausch Health Companies Inc.
(Stop Loss Kurs erreicht)
Stopped prediction by tamam for Bausch Health Companies Inc.
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€18.10
18.12.18
18.12.18
€29.80
19.12.18
19.12.18
0.00%
19.12.18
19.12.18
